The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127815271 12781527 1 I 20070605 20080110 20160926 20160926 EXP GB-PFIZER INC-18203 PFIZER 50.00 YR F Y 0.00000 20160926 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127815271 12781527 1 PS ?ALBUTEROL SULFATE INHALATION SOL, 2.5 MG NEPHRON PHARMACEUTICALS CORP ALBUTEROL SULFATE 1 Ophthalmic 10 MG, UNK 62911 10 MG POWDER FOR INJECTION
127815271 12781527 2 SS LIDOCAINE HCL LIDOCAINE HYDROCHLORIDE 1 1 DF, UNK (STRENGTH 1%) U 0 1 DF
127815271 12781527 3 SS LIDOCAINE HCL LIDOCAINE HYDROCHLORIDE 1 U 0
127815271 12781527 4 SS POVIDONE-IODINE. POVIDONE-IODINE 1 UNK D 0
127815271 12781527 5 SS OCUFEN FLURBIPROFEN SODIUM 1 Ophthalmic UNK; (STRENGTH 0.03%) U E46628 0
127815271 12781527 6 SS ADRENALINE EPINEPHRINE 1 Ophthalmic 0.3 ML, SINGLE U 0 .3 ML
127815271 12781527 7 SS BETAMETHASONE. BETAMETHASONE 1 Ophthalmic UNK U 0
127815271 12781527 8 SS CYCLOPENTOLATE HYDROCHLORIDE. CYCLOPENTOLATE HYDROCHLORIDE 1 Intraocular 1 DF, SINGLE (STRENGTH 1%) 0 1 DF
127815271 12781527 9 SS HYALURONATE SODIUM HYALURONATE SODIUM 1 Ophthalmic UNK U 0
127815271 12781527 10 SS NEOMYCIN NEOMYCIN 1 Ophthalmic UNK U 0
127815271 12781527 11 SS PHENYLEPHRINE PHENYLEPHRINEPHENYLEPHRINE HYDROCHLORIDE 1 Ophthalmic 1 DF, SINGLE D 0 1 DF CUTANEOUS SOLUTION
127815271 12781527 12 SS PROXYMETACAINE HYDROCHLORIDE PROPARACAINE HYDROCHLORIDE 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127815271 12781527 1 Eye irrigation
127815271 12781527 2 Anaesthesia
127815271 12781527 3 Cataract operation
127815271 12781527 4 Cataract operation
127815271 12781527 5 Preoperative care
127815271 12781527 6 Eye irrigation
127815271 12781527 7 Postoperative care
127815271 12781527 8 Preoperative care
127815271 12781527 9 Perioperative analgesia
127815271 12781527 10 Postoperative care
127815271 12781527 11 Preoperative care
127815271 12781527 12 Perioperative analgesia

Outcome of event

Event ID CASEID OUTC COD
127815271 12781527 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127815271 12781527 Toxic anterior segment syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127815271 12781527 1 20070530 20070530 0
127815271 12781527 2 20070530 20070530 0
127815271 12781527 4 20070530 20070530 0
127815271 12781527 5 20070530 20070530 0
127815271 12781527 6 20070530 20070530 0
127815271 12781527 7 20070530 20070530 0
127815271 12781527 8 20070530 20070530 0
127815271 12781527 9 20070530 20070530 0
127815271 12781527 10 20070530 20070530 0
127815271 12781527 11 20070530 20070530 0
127815271 12781527 12 20070530 20070530 0